Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRAMA: Azithromycin for Child Mortality Reduction in Burkina Faso
NCT04716712Phase 4Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- Oct 2021
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of azithromycin in child mortality (U5MR), sponsored by University of California, San Francisco. Started Oct 2021; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
child mortality (U5MR)
Beyond the preview
Go deeper on NCT04716712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716712.